- Home
- FROG vs ADMA Comparison
FROG vs ADMA Comparison
Compare FROG & ADMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FROG
- ADMA
- Stock Information
- Founded
- FROG 2008
- ADMA 2004
- Country
- FROG United States
- ADMA United States
- Employees
- FROG N/A
- ADMA N/A
- Industry
- FROG Computer Software: Prepackaged Software
- ADMA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- FROG Technology
- ADMA Health Care
- Exchange
- FROG Nasdaq
- ADMA Nasdaq
- Market Cap
- FROG 3.6B
- ADMA 4.7B
- IPO Year
- FROG 2020
- ADMA N/A
- Fundamental
- Price
- FROG $27.40
- ADMA $20.72
- Analyst Decision
- FROG Strong Buy
- ADMA Strong Buy
- Analyst Count
- FROG 18
- ADMA 4
- Target Price
- FROG $35.06
- ADMA $15.50
- AVG Volume (30 Days)
- FROG 1.0M
- ADMA 6.9M
- Earning Date
- FROG 10-30-2024
- ADMA 11-06-2024
- Dividend Yield
- FROG N/A
- ADMA N/A
- EPS Growth
- FROG N/A
- ADMA N/A
- EPS
- FROG N/A
- ADMA 0.15
- Revenue
- FROG $389,250,000.00
- ADMA $330,244,000.00
- Revenue This Year
- FROG $23.32
- ADMA $60.28
- Revenue Next Year
- FROG $18.44
- ADMA $13.67
- P/E Ratio
- FROG N/A
- ADMA $139.53
- Revenue Growth
- FROG 24.55
- ADMA 58.69
- 52 Week Low
- FROG $21.38
- ADMA $3.06
- 52 Week High
- FROG $48.81
- ADMA $20.92
- Technical
- Relative Strength Index (RSI)
- FROG 42.91
- ADMA 68.31
- Support Level
- FROG $27.52
- ADMA $19.10
- Resistance Level
- FROG $28.84
- ADMA $20.58
- Average True Range (ATR)
- FROG 0.80
- ADMA 0.72
- MACD
- FROG -0.04
- ADMA -0.02
- Stochastic Oscillator
- FROG 13.72
- ADMA 90.52
About FROG JFrog Ltd.
JFrog Ltd provides an end-to-end, hybrid, universal DevOps Platform that powers and controls the software supply chain, enabling organizations to continuously and securely deliver software updates across any system. Its product portfolio includes JFrog Artifactory; JFrog Pipelines; JFrog Xray; JFrog Distribution; JFrog Artifactory Edge; JFrog Mission Control and JFrog Insight. Geographically, it derives a majority of revenue from Israel and also has its presence in United States, India and other regions.
About ADMA ADMA Biologics Inc
ADMA Biologics Inc is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. The segments of the company are ADMA BioManufacturing which generates maximum revenue and Plasma Collection Centres, and corporate segment. The company sells plasma-derived intermediate fractions to certain customers, which are generated as part of its FDA-approved manufacturing process for IG and IVIG products. It also provides laboratory contracting services to certain customers and anticipates providing contract filling, labeling and packing services. The company derives maximum revenue from United States.